Zhong introduces convalescence plasma trial in COVID-19 treatment

Updated: Mar 31, 2020 chinadaily.com.cn Print

Share - WeChat

In a video consultation with US medical experts on Friday, Zhong Nanshan, a prominent Chinese respiratory disease expert, introduced convalescence plasma trial in treating the COVID-19 in China.

Editors' Picks

Highlights: Highlights of new quality productive forces: Low-altitude economy

Infographic: China extends visa-free transit to 240 hours

Video: Highlights of China's economy in 2024

Infographic: First 11 months see 749.7b yuan in China's actual use of FDI

Video: 70 years on: Pooling the wisdom of the people

Zhong introduces convalescence plasma trial in COVID-19 treatment

MOST POPULAR

Editors' Picks

LEAVE YOUR MESSAGE

*Your E-mail Address